Drugs for Systemic Mastocytosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 76)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Protein Kinase Inhibitors |
|
Phase 4 |
|
|
|
2 |
|
Imatinib Mesylate |
|
Phase 4 |
|
220127-57-1 |
|
Synonyms:
GLEEVEC
GLIVEC
IMATINIB MESILATE
IMATINIB MESYLATE
|
IMATINIB METHANESULFONATE
STI571
STI-571
|
|
3 |
|
Cladribine |
Approved, Investigational |
Phase 3 |
|
4291-63-8 |
20279 |
Synonyms:
(2R,3S,5R)-5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
2-CdA
2-Chloro-2'-deoxyadenosine
2-Chloro-2'-deoxy-b-adenosine
2-Chloro-2'-deoxy-beta-adenosine
2-Chloro-2'-deoxy-β-adenosine
2-Chloro-6-amino-9-(2-deoxy-b-D-erythro-pentofuranosyl)purine
2-Chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine
2-Chloro-6-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)purine
2-Chlorodeoxyadenosine
2-Chloro-deoxyadenosine
2ClAdo
2'-Deoxy-2-chloroadenosine
Chlorodeoxyadenosine
|
CLADARIBINE
Cladribina
CLADRIBINE
Cladribinum
CldAdo
LEUSTAT
Leustatin
LITAK
Mavenclad
Mylinax
NSC-05014
NSC-105014
NSC-105014-F
RWJ-26251
|
|
4 |
|
Denosumab |
Approved |
Phase 3 |
|
615258-40-7 |
|
Synonyms:
AMG-162
Denosumab
PROLIA
PROLIA, RANMARK XGEVA
|
PROLIA, XGEVA
TK006
TK-006
XGEVA
|
|
5 |
|
Hydroxychloroquine |
Approved |
Phase 2, Phase 3 |
|
118-42-3 |
3652 |
Synonyms:
(+-)-Hydroxychloroquine
(±)-HYDROXYCHLOROQUINE
2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol
2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol
7-Chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(N-ethyl-N-b-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(N-ethyl-N-β-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-[4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline
7-Chloro-4-[4-(N-ethyl-N-b-hydroxyethylamino)-1-methylbutylamino]quinoline
7-Chloro-4-[4-(N-ethyl-N-β-hydroxyethylamino)-1-methylbutylamino]quinoline
7-Chloro-4-[5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline
Axemal
DOLQUINE
Dolquine®|Plaquenil®
Ercoquin
Gen-Hydroxychloroquine 200mg Tablets
HCQ
Hidroxicloroquina
|
Hidroxicloroquina [inn-spanish]
Hydroxychlorochin
Hydroxychloroguine
HYDROXYCHLOROQUINE
Hydroxychloroquine sulfate
Hydroxychloroquine sulfate (1:1) salt
Hydroxychloroquinum
Hydroxychloroquinum [inn-latin]
Idrossiclorochina [dcit]
NSC4375
Oxichlorochine
Oxichlorochinum
Oxichloroquine
Oxychlorochin
Oxychloroquine
Plaquenil
Polirreumin
Quensyl
|
|
6 |
|
2-chloro-3'-deoxyadenosine |
|
Phase 3 |
|
|
14485373 |
7 |
|
interferons |
|
Phase 3 |
|
|
|
8 |
|
Interferon-alpha |
|
Phase 3 |
|
|
|
9 |
|
Cromolyn Sodium |
|
Phase 3 |
|
|
|
Synonyms:
AEROCROM
ALLERCROM
ASPIRE
BROL-EZE
CATACROM
CLARITEYES
CROLOM
CROMOGEN
CROMOGEN E-BREATHE
CROMOGLICATE SODIUM
CROMOGLYCIC ACID
CROMOLUX
CROMOLYN
CROMOLYN DISODIUM SALT
CROMOLYN SODIUM
CROMOPTIC
CROMOSOL
CROMOSOL OPTHA
CUSILYN
DOMINION PHARMA HAYFEVER
EYE-CROM
FPL-670
GASTROCROM
|
GLYCAVENT
GPPE SYNCRONER INHA
HAY-CROM
INTAL
INTAL 5
LOMUDAL
LOMUSOL
MURINE
NALCROM
NASALCROM
NSC-109500
OPTICROM
OPTICROM AQ
RESISTON ONE
RESISTON TREATMENT PACK
RYNACROM
RYNACROM ALLERGY
RYNACROM CO
SODIUM CROMOGLICATE
STERI-NEB CROMOGEN
VIVICROM
VIVIDRIN
VIZ-ON
|
|
10 |
|
Leukotriene Antagonists |
|
Phase 3 |
|
|
|
11 |
|
Proton Pump Inhibitors |
|
Phase 3 |
|
|
|
12 |
|
Antidepressive Agents |
|
Phase 3 |
|
|
|
13 |
|
Histamine H1 Antagonists |
|
Phase 3 |
|
|
|
14 |
|
Histamine Antagonists |
|
Phase 3 |
|
|
|
15 |
|
Pharmaceutical Solutions |
|
Phase 3 |
|
|
|
16 |
|
Antirheumatic Agents |
|
Phase 2, Phase 3 |
|
|
|
17 |
|
Anti-Infective Agents |
|
Phase 2, Phase 3 |
|
|
|
18 |
|
Antiprotozoal Agents |
|
Phase 2, Phase 3 |
|
|
|
19 |
|
Antiparasitic Agents |
|
Phase 2, Phase 3 |
|
|
|
20 |
|
Antimalarials |
|
Phase 2, Phase 3 |
|
|
|
21 |
|
Dasatinib |
Approved, Investigational |
Phase 2 |
|
302962-49-8 |
3062316 |
Synonyms:
(18F)-N-(2-Chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide
Anh. dasatinib
Anhydrous dasatinib
BMS 345825
BMS 345825|BMS 354825|BMS 35482513|Sprycel®
BMS 354825
BMS 35482513
BMS Dasatinib
BMS-354825
BMS-354825 HYDRATE
BMS-354825-03
|
DASATINIB
Dasatinib (anh.)
dasatinib (anhydrous)
DASATINIB ANHYDROUS
DASATINIB HYDRATE
DASATINIB MONOHYDRATE
Dasatinibum
N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide
N-(2-Chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide
Sprycel
|
|
22 |
|
Brentuximab vedotin |
Approved, Investigational |
Phase 2 |
|
914088-09-8 |
|
Synonyms:
124490327
ADCETRIS
Adcetris®|anti-CD30 ADC SGN-35|SGN 35
Brentuximab
BRENTUXIMAB VEDOTIN
Brentuximab vedotin brentuximab
|
Brentuximab vedotina
CAC10-VCMMAE
Moab, chimeric, SGN-30, to CD30 antigen
Monoclonal antibody SGN-30
SGN-35
|
|
23 |
|
Everolimus |
Approved |
Phase 2 |
|
159351-69-6 |
70789204 6442177 |
Synonyms:
001, RAD
40-O-(2-Hydroxyethyl)-rapamycin
42-O-(2-HYDROXYETHYL)RAPAMYCIN
Afinitor
AFINITOR DISPERZ
Afinitor®|Certican®|RAD-001|RAD001|rapamycin, 42-O-(2-hydroxyethyl)-|Zortress®
Certican
EVEROLIMUS
évérolimus
RAD 001
|
RAD 666
RAD, SDZ
RAD001
RAD-001
RAD-666
SDZ RAD
SDZ-RAD
VOTUBIA
ZORTRESS
|
|
24 |
|
Denileukin diftitox |
Approved, Investigational |
Phase 2 |
|
173146-27-5 |
|
Synonyms:
DAB(SUB 389)IL2
DAB389 IL2
DAB389IL2
DAB-389IL2
Denileukin
DENILEUKIN DIFTITOX
DIPHTHERIA TOXIN PRECURSOR
DT
|
E7272
E7777
Interleukin-2/diptheria toxin fusion protein
LY335348
LY-335348
NAD(+--DIPHTHAMIDE ADP- RIBOSYLTRANSFERASE)
ONTAK
|
|
25 |
|
Midostaurin |
Approved, Investigational |
Phase 2 |
|
120685-11-2 |
9829523 |
Synonyms:
4'-N-BENZOYLSTAUROSPORINE
BENZOYLSTAUROSPORINE
CGP 41231
CGP 41231|CGP 41251|N-benzoylstaurosporine|PKC412|Rydapt®
CGP 41251
CGP-41251
MIDOSTAURIN
|
N-BENZOYLSTAUROSPORINE
NVP-PKC412
PKC 412
PKC412
PKC-412
RYDAPT
|
|
26 |
|
Fludarabine |
Approved |
Phase 2 |
|
75607-67-9, 21679-14-1 |
30751 657237 |
Synonyms:
2-F-ARAA
2-F-Ara-A|CCRIS 3382|F-Ara-A|Fludara®
2F-Ara-AMP
2-fluoro ARA-A
2-Fluoroadenine arabinoside 5'-monophosphate
2-Fluoroadenine arabinoside 5'-monophosphoric acid
2-Fluoro-ara AMP
2-FLUORO-ARA-A
9 beta-D-Arabinofuranosyl-2-fluoroadenine monophosphate
9-b-Arabinofuranosyl-2-fluoroadenine-5'-phosphate
9-b-Arabinofuranosyl-2-fluoroadenine-5'-phosphoric acid
9-b-D-Arabinofuranosyl-2-fluoroadenine 5'-(dihydrogen phosphate)
9-b-D-Arabinofuranosyl-2-fluoroadenine 5'-(dihydrogen phosphoric acid)
9-b-D-Arabinofuranosyl-2-fluoroadenine 5'-monophosphate
9-b-D-Arabinofuranosyl-2-fluoroadenine 5'-monophosphoric acid
9-beta-Arabinofuranosyl-2-fluoroadenine-5'-phosphate
9-beta-Arabinofuranosyl-2-fluoroadenine-5'-phosphoric acid
9-beta-D-Arabinofuranosyl-2-fluoroadenine 5'-(dihydrogen phosphate)
9-beta-D-Arabinofuranosyl-2-fluoroadenine 5'-(dihydrogen phosphoric acid)
9-beta-D-Arabinofuranosyl-2-fluoroadenine 5'-monophosphate
9-beta-D-Arabinofuranosyl-2-fluoroadenine 5'-monophosphoric acid
9-Β-arabinofuranosyl-2-fluoroadenine-5'-phosphate
9-Β-arabinofuranosyl-2-fluoroadenine-5'-phosphoric acid
|
9-Β-D-arabinofuranosyl-2-fluoroadenine 5'-(dihydrogen phosphate)
9-Β-D-arabinofuranosyl-2-fluoroadenine 5'-(dihydrogen phosphoric acid)
9-Β-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate
9-Β-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphoric acid
Beneflur
FAMP
FaraAMP
F-Ara-AMP
Fludara
Fludarabina
FLUDARABINE
Fludarabine 5'-monophosphate
Fludarabine 5'-monophosphoric acid
Fludarabine monophosphate
Fludarabine monophosphoric acid
Fludarabine phosphate
Fludarabine phosphoric acid
Fludarabinum
Fludura
Fluoro-ara-AMP
NSC-312887
NSC-328002
OFORTA
|
|
27 |
|
Cyclophosphamide |
Approved, Investigational |
Phase 2 |
|
50-18-0, 6055-19-2 |
2907 |
Synonyms:
(+-)-Cyclophosphamide
(+,-)-2-(Bis(2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide monohydrate
(RS)-Cyclophosphamide
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
Anhydrous cyclophosphamide
Anhydrous, cyclophosphamide
ASTA
Asta B 518
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
Ciclofosfamida
Ciclofosfamide
Clafen
Claphene
CP
CPA
CTX
CY
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide anhydrous
Cyclophosphamide monohydrate
Cyclophosphamide Sterile
Cyclophosphamide, (R)-isomer
Cyclophosphamide, (S)-isomer
Cyclophosphamidum
Cyclophosphan
Cyclophosphane
Cyclophosphoramide
|
Cyclostin
Cyklofosfamid
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan Lyoph
Endoxan
Endoxan R
Endoxana
Endoxanal
Endoxan-Asta
Endoxane
Enduxan
Genoxal
Hexadrin
LEDOXINA
Lyophilized Cytoxan
Mitoxan
Monohydrate, cyclophosphamide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
Neosar
Procytox
Rcra Waste Number U058
Revimmune
Semdoxan
Sendoxan
Senduxan
Zyklophosphamid
|
|
28 |
|
Thalidomide |
Approved, Investigational, Withdrawn |
Phase 2 |
|
50-35-1 |
5426 |
Synonyms:
(+-)-N-(2,6-DIOXO-3-PIPERIDYL)PHTHALIMIDE
(+-)-THALIDOMIDE
(±)-N-(2,6-DIOXO-3-PIPERIDYL)PHTHALIMIDE
(±)-THALIDOMIDE
1,3-DIOXO-2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE
2,6-DIOXO-3-PHTHALIMIDOPIPERIDINE
3-PHTHALIMIDOGLUTARIMIDE
Algosediv
ALPHA-(N-PHTHALIMIDO)GLUTARIMIDE
ALPHA-N-PHTHALYLGLUTARAMIDE
alpha-Phthalimidoglutarimide
Asidon 3
Asmadion
Asmaval
Bonbrain
Bonbrrin
Calmore
Calmorex
Celgene brand OF thalidomide
Contergan
Corronarobetin
Distaval
Distaxal
Distoval
Ectiluran
Enterosediv
Gastrinide
Glupan
Glutanon
Grippex
Hippuzon
Imida-Lab
Imidan
Imidene
Isomin
K-17
Kedavon
Kevadon
Lulamin
N-(2,6-DIOXO-3-PIPERIDYL)PHTHALIMIDE
Neaufatin
Neo
Neosedyn
Neosydyn
Nerosedyn
Neufatin
Neurodyn
Neurosedin
Neurosedym
Neurosedyn
Nevrodyn
Nibrol
Noctosediv
Noxodyn
|
N-Phthalimidoglutamic acid imide
N-Phthaloylglutamimide
N-Phthalylglutamic acid imide
N-PHTHALYL-GLUTAMINSAEURE-IMID
NSC-527179
NSC-66847
Pangul
Pantosediv
Poly-Giron
Polygripan
Predni-Sediv
Pro-ban M
Profarmil
Psycholiquid
Psychotablets
Quetimid
Quietoplex
Sandormin
Sedalis
Sedalis sedi-lab
Sedimide
Sedin
Sedisperil
Sedoval
Shin-naito S
Shinnibrol
Sleepan
Slipro
Softenil
Softenon
Talargan
TALIDEX
TALIDOMIDA
Talimol
Talismol
Telagan
Telargan
Telargean
Tensival
Thaled
Thalidomide
THALIDOMIDUM
Thalidomine usp26
Thalin
Thalinette
Thalomid
Theophilcholine
Valgis
Valgraine
Yodomin
Α-(N-PHTHALIMIDO)GLUTARIMIDE
Α-N-PHTHALYLGLUTARAMIDE
Α-PHTHALIMIDOGLUTARIMIDE
|
|
29 |
|
Azacitidine |
Approved, Investigational |
Phase 1, Phase 2 |
|
320-67-2 |
9444 |
Synonyms:
4-Amino-1-b-D-ribofuranosyl-S-triazin-2(1H)-one
4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one
4-Amino-1-β-D-ribofuranosyl-S-triazin-2(1H)-one
5 Azacytidine
5 AZC
5-AZAC
5-azacytidine
Azacitidina
|
Azacitidine
Azacitidinum
Azacytidine
LADAKAMYCIN
NSC-102816
Pharmion brand OF azacitidine
U-18496
Vidaza
|
|
30 |
|
D-Tyrosine |
Approved, Experimental, Investigational, Nutraceutical |
Phase 2 |
|
133585-56-5, 60-18-4, 556-02-5 |
1153 6057 |
Synonyms:
(-)-a-Amino-p-hydroxyhydrocinnamate
(-)-a-Amino-p-hydroxyhydrocinnamic acid
(-)-alpha-Amino-p-hydroxyhydrocinnamate
(-)-alpha-Amino-p-hydroxyhydrocinnamic acid
(-)-Α-amino-p-hydroxyhydrocinnamate
(−)-α-amino-p-hydroxyhydrocinnamic acid
(-)-Α-amino-p-hydroxyhydrocinnamic acid
(2S)-2-Amino-3-(4-hydroxyphenyl)propanoate
(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid
(2S)-2-AMINO-3-(4-HYDROXYPHENYL)PROPIONIC ACID
(2S)-2-AZANYL-3-(4-HYDROXYPHENYL)PROPANOIC ACID
(R)-2-Amino-3-(p-hydroxyphenyl)propionic acid
(R)-3-(p-Hydroxyphenyl)alanine
(S)-(-)-Tyrosine
(S)-2-Amino-3-(p-hydroxyphenyl)propionate
(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid
(S)-3-(p-Hydroxyphenyl)alanine
(S)-a-Amino-4-hydroxybenzenepropanoate
(S)-a-Amino-4-hydroxy-benzenepropanoate
(S)-a-Amino-4-hydroxybenzenepropanoic acid
(S)-a-Amino-4-hydroxy-benzenepropanoic acid
(S)-alpha-Amino-4-hydroxybenzenepropanoate
(S)-alpha-Amino-4-hydroxy-benzenepropanoate
(S)-alpha-amino-4-Hydroxybenzenepropanoic acid
(S)-alpha-Amino-4-hydroxy-benzenepropanoic acid
(S)-Tyrosine
(S)-Α-amino-4-hydroxybenzenepropanoate
(S)-α-amino-4-hydroxybenzenepropanoic acid
2-Amino-3-(4-hydroxyphen yl)-2-amino-3-(4-hydroxyphenyl)-propanoate
2-Amino-3-(4-hydroxyphen yl)-2-amino-3-(4-hydroxyphenyl)-propanoic acid
2-Amino-3-(4-hydroxyphenyl)propanoate
|
2-Amino-3-(4-hydroxyphenyl)propanoic acid
2-Amino-3-(p-hydroxyphenyl)propionate
2-Amino-3-(p-hydroxyphenyl)propionic acid
3-(4-Hydroxyphenyl)-L-alanine
3-(p-Hydroxyphenyl)alanine
4-hydroxy-L-phenylalanine
6-Hydroxysandoricin
Benzenepropanoate
Benzenepropanoic acid
D-Tyr
D-Tyrosin
FEMA NO. 3736
L Tyrosine
LEVODOPA IMPURITY, L-TYROSINE-
LEVODOPA RELATED COMPOUND L-TYROSINE
L-p-Tyrosine
L-Tyrosin
L-tyrosine
Methyl 2-[5,11-bis(acetyloxy)-13-(furan-3-yl)-16-hydroxy-6,6,8,12-tetramethyl-17-methylidene-15-oxo-2,14-dioxatetracyclo[7.7.1.0¹,¹².0³,⁸]heptadecan-7-yl]-2-hydroxyacetic acid
NSC-82624
Para tyrosine
Para-tyrosine
p-Tyrosine
Tirosina
Tyr
Tyrosin
Tyrosine
Tyrosine, L isomer
Tyrosine, L-isomer
Tyrosinum
Y
|
|
31 |
|
Obatoclax |
Investigational |
Phase 2 |
|
803712-67-6 |
46930997 |
Synonyms:
GX15-070
GX-15-070|GX15-070|obatoclax mesylate|SB16622
|
|
|
32 |
|
Immunoconjugates |
|
Phase 2 |
|
|
|
33 |
|
Antineoplastic Agents, Immunological |
|
Phase 2 |
|
|
|
34 |
|
Immunologic Factors |
|
Phase 2 |
|
|
|
35 |
|
Immunosuppressive Agents |
|
Phase 2 |
|
|
|
36 |
|
Interleukin-2 |
|
Phase 2 |
|
|
|
37 |
|
Anti-Bacterial Agents |
|
Phase 2 |
|
|
|
38 |
|
Angiogenesis Inhibitors |
|
Phase 2 |
|
|
|
39 |
|
Antigen-Antibody Complex |
|
Phase 2 |
|
|
|
40 |
|
Antimetabolites |
|
Phase 1, Phase 2 |
|
|
|
41 |
|
Dexamethasone acetate |
Approved, Investigational, Vet_approved |
Phase 1 |
|
1177-87-3 |
3680 |
Synonyms:
16alpha-Methyl-9alpha-fluoroprednisolone 21-acetate
2-{1-fluoro-14,17-dihydroxy-2,13,15-trimethyl-5-oxotetracyclo[8.7.0.0,.0,]heptadeca-3,6-dien-14-yl}-2-oxoethyl acetic acid
9alpha-Fluoro-16alpha-methylprednisolone acetate
DECADRON-LA
Dexamethasone 21-acetate
|
DEXAMETHASONE ACETATE
Dexamethasone acetate anhydrous
Dexamethasone acetate, anhydrous
Dexamethasone acetic acid
Dexamethasoni acetas
|
|
42 |
|
Dexamethasone |
Approved, Investigational, Vet_approved |
Phase 1 |
|
50-02-2 |
3003 5743 |
Synonyms:
[<sup>3</sup>H]-dexamethasone
16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol
16alpha -Methyl-9alpha -fluoroprednisolone
16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone
16alpha-Methyl-9alpha-fluoroprednisolone
16-alpha-Methyl-9-alpha-fluoroprednisolone
16a-Methyl-9a-fluoro-1-dehydrocortisol
16Α-methyl-9α-fluoro-1-dehydrocortisol
1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone
1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone
1-Dehydro-16a-methyl-9a-fluorohydrocortisone
1-Dehydro-16α-methyl-9α-fluorohydrocortisone
9a-Fluoro-16a-methylprednisolone
9a-Fluoro-16BETA-methylprednisolone
9alpha -Fluoro-16alpha -methylprednisolone
9alpha-Fluoro-16alpha-methylprednisolone
9alpha-Fluoro-16alpha-methyl-prednisolone
9-alpha-Fluoro-16-alpha-methylprednisolone
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione
9-Fluoro-16-methylprednisolone
9Α-fluoro-16α-methylprednisolone
Adexone
Aeroseb-D
Aeroseb-dex
Ak dex OPH otic soln 0.1%
Alcon brand OF dexamethasone
alpha -Fluoro-16-alpha -methylcortisol
Anaflogistico
Aphtasolon
Aphthasolone
Apo-dexamethasone
Auxiron
Azimycin (veterinary)
Azium
Azium (veterinary)
Bisu DS
Calonat
Corson
Corsone
Cortisumman
DALALONE
Decacort
Decacortin
Decaderm
Decadron
Decadron Tablets, Elixir
Decadron®|desametasone|fluormethylprednisolone
DECADRON-75
DECADRON-LA
Decagel
Decaject
Decaject l.a.
Decaject-l.a.
Decalix
Decameth
Decasone
Decaspray
Dectancyl
Dekacort
Delta1-9alpha-Fluoro-16alpha-methylcortisol
Deltafluorene
Dergramin
Deronil
Desadrene
Desametasone
Desametasone [Dcit]
Desamethasone
Desameton
Deseronil
DEX
DEXA
Dexa mamallet
DEXACEN-4
Dexacidin
Dexacort
Dexacortal
Dexa-cortidelt
Dexacortin
Dexa-cortisyl
DEXACORTISYL
Dexadeltone
Dexafarma
DEXAFREE
DEXAIR
Dexalona
Dexaltin
Dexa-Mamallet
Dexametasona
Dexametasona [INN-Spanish]
Dexametasone
Dexameth
Dexamethansone
DEXAMETHASONE
Dexaméthasone
Dexamethasone acetate
Dexamethasone alcohol
Dexamethasone base
Dexamethasone intensol
DEXAMETHASONE METASULFOBENZOATE SODIUM
DEXAMETHASONE PALMITATE
Dexamethasone sodium phosphate
|
DEXAMETHASONE VALERATE
Dexamethasone-omega
Dexamethasonum
Dexamethasonum [INN-Latin]
Dexamethazone
Dexamonozon
Dexapolcort
Dexapos
Dexaprol
Dexa-scheroson
Dexa-sine
Dexason
Dexasone
Dexasone 0.5MG
Dexasone 0.75MG
Dexasone 4MG
Dexasporin
Dex-ide
Dexinolon
Dexinoral
Dexone
DEXONE 0.5
DEXONE 0.75
DEXONE 1.5
DEXONE 4
Dexonium
Dexpak
DEXSOL
Dextelan
DEXTENZA
DEXYCU KIT
Dezone
Dinormon
DROPODEX
DXM
DXM833
DXMS
ECR brand OF dexamethasone
Fluormethylprednisolone
Fluormone
Fluorocort
Fortecortin
Foy brand OF dexamethasone
Gammacorten
GPPE EAR SPY
Hexadecadrol
Hexadrol
Hexadrol elixir
Hexadrol Tablets
HL-Dex
ICN brand OF dexamethasone
IontoDex
Isopto-dex
ISV-305
KORTICO INJECTION
Lokalison F
Loverine
Luxazone
MARTAPAN
Maxidex
Maxidex ont 0.1%
Maxidex sus 0.1%
Maxitrol
Mediamethasone
Merck brand OF dexamethasone
Merz brand 1 OF dexamethasone
Merz brand 2 OF dexamethasone
Methylfluorprednisolone
Mexidex
Millicorten
Mymethasone
Naquasone (veterinary)
NEODECADRON
Neomycin and polymyxin b sulfates and dexamethasone
Neomycin and polymyxin b sulphates and dexamethasone
NSC 34521
NSC-34521
Ocu-trol
Oradexon
OTO-104
OTOMIZE
OZURDEX
Pet derm III
Pet-Derm Iii
PHL-Dexamethasone
PMS Dexamethasone elixir 0.5mg/5ML
PMS-Dexamethasone
Policort
Posurdex
Prednisolon F
Prednisolone F
Prodex
Sandoz dexamethasone
SK-Dexamethasone
SOFRADEX
SPERSADEX COMP
Spoloven
Sunia sol D
Superprednol
Tobradex
Tobramycin and dexamethasone
Tresaderm (veterinary)
Turbinaire
Visumetazone
|
|
43 |
|
Acetaminophen |
Approved |
Phase 1 |
|
103-90-2 |
1983 |
Synonyms:
4-(Acetylamino)phenol
4-Acetamidophenol
4-Acetaminophenol
4'-Hydroxyacetanilide
4-Hydroxyacetanilide
4-Hydroxyanilid kyseliny octove
A.F. anacin
ABDINE
Abenol
Abensanil
Abrol
Abrolet
Acamol
Accu-tap
Acenol
Acephen
Acertol
Aceta elixir
Aceta tablets
Acetaco
Acetagesic
Acetalgin
Acetamidophenol
Acetaminofen
ACETAMINOFÉN
ACETAMINOPHEN
Acetaminophen uniserts
acetaminophen|Panadol®|Tylenol®
Acetaminophene
ACÉTAMINOPHÈNE
Acetamol
Acetofen
Acetominophen
Actamin
Actamin extra
Actamin super
Actifed plus
Actimol
Actimol chewable tablets
Actimol children's suspension
Actimol infants' suspension
Actimol junior strength caplets
Actron
Afebrin
Afebryl
Aferadol
Algesidal
Algina
Algomol
Algotropyl
Allay
alpha-Per
Alpiny
Alpinyl
Alvedon
Amadil
Aminofen
Aminofen max
Anacin
Anacin 3
Anacin3
Anacin-3
Anacin-3 extra strength
Anadin dla dzieci
Anaflon
Analter
Anapap
Andox
Anelix
Anexsia
Anexsia 10/660
Anexsia 5/325
Anexsia 7.5/325
Anexsia 7.5/650
ANGIERS
Anhiba
Anoquan
Anti-algos
Antidol
Apacet
Apacet capsules
Apacet elixir
Apacet extra strength caplets
Apacet extra strength tablets
Apacet regular strength tablets
Apadon
Apamid
Apamide
APAP
a-Per
Apitrelal
Apo-acetaminophen
Arfen
Asetam
Asomal
Aspac
Aspirin free anacin maximum strength caplets
Aspirin free anacin maximum strength gel caplets
Aspirin free anacin maximum strength tablets
Aspirin-free anacin
Aspirin-free excedrin caplets
Asplin
Atasol
Atasol caplets
Atasol drops
Atasol forte caplets
Atasol forte tablets
Atasol oral solution
Atasol tablets
Atralidon
Babikan
Bacetamol
Bancap
Bancap HC
Banesin
Bayer Select
Bayer select allergy-sinus
Bayer select head cold
Bayer select headache pain
Bayer select maximum strength headache pain relief formula
Bayer select menstrual multi-symptom
Bayer select sinus pain relief
Benmyo
Ben-u-ron
Bickie-mol
Biocetamol
Bucet
Butalbital
Butapap
Cadafen
Calapol
Calmanticold
Calpol
CALPOL SIX PLUS
CALPOL SIX PLUS FASTMELTS
Capital with codeine
Captin
Causalon
Cefalex
Cetadol
CHILD LEMSIP
Children'S acetaminophen elixir drops
Children'S acetaminophen oral solution
Children'S tylenol chewable
Claradol codeine
Clixodyne
Codabrol
COD-Acamol forte
Codalgin
Codapane
Codicet
Codisal
Codisal forte
Codoliprane
Codral pain relief
Cofamol
CO-Gesic
Conacetol
Contac cough & sore throat formula
Contra-schmerz p
Coricidin
Coricidin D
Coricidin sinus
Cosutone
Croix blanche
CUPANOL
Cuponol
Curadon
Curpol
Custodial
DAFALGAN
Dapa
Dapa X-S
Darocet
Darvocet
Darvocet-N 50
Datril
Datril extra-strength
Daygrip
Demilets
Deminofen
Democyl
Demogripal
Desfebre
Dhamol
DHC Plus
Dial-a-gesic
Dial-alpha-gesic
Dimindol
Dirox
Disprol
DISPROL INFANT
DISPROL JNR
DISPROL PAED
Dolcor
Dolefin
Dolegrippin
Dolene ap-65
Dolgesic
Doliprane
Dolko
Dolofugin
Doloreduct
Dolorfug
Dolorol forte
Dolorstop
Dolotec
Dolprone
Dol-stop
Dorocoff
Dresan
Dristan cold no drowsiness
Dristancito
Drixoral Plus
Dularin
Duracetamol
Duradyne DHC
Durapan
Dymadon
Dymadon co
Dymadon forte
Dypap
Ecosetol
Elixodyne
Empracet
Endecon
Enelfa
Eneril
Esgic
Esgic-plus
Eu-med
Excedrin
Excedrin caplets
Excedrin extra strength caplets
Excipain
Exdol
Exdol strong
Fanalgic
Farmadol
Febranine
Febrectal
Febrectol
Febrex
Febricet
Febridol
Febrilix
Febrin
Febrinol
Febro-gesic
Febrolin
Femcet
Fendon
FENNINGS
Fensum
Fepanil
Feverall
Feverall junior strength
Feverall sprinkle caps junior strength
Fevor
Finimal
Finiweh
Fioricet
Fluparmol
Fortalidon p
Freka-cetamol
GALPAMOL
Gattaphen T
Gelocatil
Geluprane
Genapap
Genapap children's elixir
Genapap children's tablets
Genapap extra strength caplets
Genapap extra strength tablets
Genapap regular strength tablets
Genebs
Genebs extra strength caplets
Genebs regular strength tablets
Genebs X-tra
Geralgine-p
Gripin bebe
Grippostad
Gynospasmine
Hedex
Helon N
Homoolan
Hycomine compound
Hydrocet
Hydroxyacetanilide
Hy-phen
Ildamol
Inalgex
Infadrops
Infants' feverall
Influbene N
Injectapap
Intensin
Janupap
Junior disprol
JUNIOR PARAPAED
Kataprin
Kinder finimal
Korum
Kratofin simplex
Labamol
Lekadol
Lemgrip
Lemsip
Lestemp
Liquagesic
Liquigesic co
Liquiprin
Liquiprin children's elixir
Liquiprin infants" drops
Lonarid
Lonarid mono
Lorcet-HD
Lortab
Lupocet
Lyteca
Lyteca syrup
Magnidol
Malex N
Malgis
Malidens
MANDANOL
Maxadol
Medigesic plus
MEDINOL
MEDINOL FOR CHILDREN
MEDINOL OVER 6
Medinol paediatric
MEDINOL UNDER 6
MEDISED PLAIN
Medocodene
Melabon infantil
Mexalen
Midol maximum strength
Midol PM night time formula
Midol regular strength
Midol teen formula
Migraleve yellow
Minafen
Minoset
MIRADOL
Miralgin
Momentum
|
mono Praecimed
Multin
N-(4-Hydroxyphenyl)acetamide
N-(4-Hydroxyphenyl)acetanilide
N-Acetyl-4-aminophenol
N-Acetyl-p-aminophenol
Naldegesic
NAPA
Napafen
Napap
Naprinol
Nealgyl
Nebs
NeoCitran
Neodol
Neodolito
Neo-fepramol
Neopap
Neotrend
Neuridon
New cortal for children
NilnOcen
Nina
Nobedon
Nodolex
NO-Febril
Noral
Norcet
Norco
NSC-109028
NSC-3991
O-Acetaminophenol
OFIRMEV
Oltyl
Oralgan
Oraphen-PD
Ortensan
Oxycet
Oxycocet
Oxycodone 2.5/apap 500
Oxycodone 5/apap 500
p-(Acetylamino)phenol
Paceco
Pacemo
Pacemol
Pacet
p-Acetamidophenol
p-Acetaminophenol
p-Acetylaminophenol
Pacimol
Paedialgon
Paedol
Painex
Paldesic
Pamol
Panacete
Panadeine
Panadeine co
Panadiene
PANADO
Panado-co
Panado-co caplets
Panadol
PANADOL ACTIFAST
PANADOL ACTIFAST SOLB
PANADOL ADVAN
Panadol extra strength
PANADOL JNR
Panadol junior strength caplets
Panadol maximum strength caplets
Panadol maximum strength tablets
PANADOL OA
Panaleve
PANALEVE 6 PLUS
Panamax
Panasorb
Panasorbe
Panets
Panex
Panodil
Panofen
Pantalgin
Papa-Deine
Papa-deine #3
Papa-deine #4
Paracemol
Paracenol
Paracet
Paracetamol
PARACÉTAMOL
Paracetamol al
Paracetamol antipanin p
Paracetamol basics
Paracetamol BC
Paracetamol DC
Paracetamol dr. schmidgall
Paracetamol fecofar
Paracetamol genericon
Paracetamol hanseler
Paracetamol harkley
Paracetamol heumann
Paracetamol hexal
Paracetamol italfarmaco
Paracetamol nycomed
Paracetamol PB
Paracetamol raffo
Paracetamol ratiopharm
Paracetamol rosch
Paracetamol saar
Paracetamol smithkline beecham
Paracetamol stada
Paracetamol von CT
Paracetamol winthrop
Paracetamole
Paracetamolo
Paracetamolum
Paracetanol
Paracetol
Paracin
Paracod
Paracodol
Parador
Paradrops
Parakapton
Parake
Paralen
Paralief
Paralink
Paralyoc
PARAMIN
Paramol
Paramolan
Paranox
PARAPAED JNR
PARAPAED SIX PLUS
Parapan
Parasedol
Parasin
Paraspen
Para-suppo
Para-tabs
PARAVICT
Parcetol
Parelan
Parmol
Parogal
Paroma
Pasolind
Pasolind N
PCM Paracetamol lichtenstein
Pediapirin
Pediatrix
Pedric
Percocet
Percocet-5
Percocet-demi
Percogesic with codeine
Perdolan mono
PERFALGAN
Pe-tam
Phenaphen
Phenaphen caplets
Phenaphen w/codeine
Phendon
Phenipirin
Phogoglandin
Phrenilin
Phrenilin forte
P-HYDROXY-ACETANILID
p-Hydroxyacetanilide
p-Hydroxyphenolacetamide
Pinex
Piramin
Pirinasol
PLACIDEX
Plicet
Polmofen
Predimol
Predualito
Prestwick_13
Prodol
Prompt
Prontina
Propacet
Propacet 100
Proval #3
Puernol
Pulmofen
Pyregesic-C
Pyrigesic
Pyrinazine
Pyromed
Quiet world
Redutemp
Reliv
Remedol
Rhinex D-lay tablets
RIMADOL
Rivalgyl
Robigesic
Robitussin night relief
Rockamol plus
Rounox
Roxicet
Roxicet 5/500
Roxilox
RubieMol
Rubophen
Rupemol
Salzone
Sanicet
Sanicopyrine
Scanol
Scentalgyl
Scherzatabletten rezeptur 534
Schmerzex
Sedalito
Sedapap
Semolacin
Servigesic
Seskamol
Setakop
Setamol
Setol
Sifenol
Sinaspril
Sinedol
Sine-OFF sinus medicine caplets
Sinmol
Sinubid
SK-Apap
Snaplets-FR
Spalt fur die nacht
Spalt N
ST Joseph aspirin-free
ST Joseph aspirin-free for children
St. joseph cold tablets for children
St. joseph fever reducer
Stanback
Stopain
Sudafed severe cold formula
Sudafed sinus
Sunetheton
Supac
Supadol mono
Supofen
Suppap
Suppap-120
Suppap-325
Suppap-650
Supramol-m
Synalgos-DC-a
Tabalgin
Tachiprina
Talacen
Tapanol
Tapanol extra strength caplets
Tapanol extra strength tablets
Tapar
Tavist allergy/sinus/headache
Tazamol
Temlo
Tempanal
Tempra
Tempra caplets
Tempra chewable tablets
Tempra d.s
Tempra drops
Tempra syrup
Tencon
Termacet
Termalgin
Termalgine
Termofren
TheraFlu
Tibinide
Tibizide
Tiffy
Tisin
Tisiodrazida
Titralgan
TIXYMOL
Tizide
Tocris-1706
Toximer p
Tralgon
TRAMIL 500
Treupel mon
Treupel N
Treuphadol
Triad
Triaminic sore throat formula
Triaprin
Tricoton
Tussapap
Tycolet
TYL
Tylenol
Tylenol allergy sinus
Tylenol arthritis extended relief
Tylenol caplets
Tylenol children's chewable tablets
Tylenol children's elixir
Tylenol children's suspension liquid
Tylenol drops
Tylenol elixir
Tylenol extra strength adult liquid pain reliever
Tylenol extra strength caplets
Tylenol extra strength gelcaps
Tylenol extra strength tablets
Tylenol gelcaps
Tylenol infants drops
Tylenol infants" suspension drops
Tylenol junior strength caplets
Tylenol junior strength chewable tablets
Tylenol regular strength caplets
Tylenol regular strength tablets
Tylenol tablets
Tylex
Tylex CD
Tylol
Tylox
Tylox-325
Tymol
Ultracet
Upsanol
Utragin
Valadol
Valgesic
Valorin
Valorin extra
Vanquish
Veralgina
Vermidon
Verpol
Viclor richet
Vicodin
Vicodin es
Vicodin HP
Vips
Viruflu
Vivimed
Volpan
Wygesic
Zatinol
Zolben
|
|
44 |
|
Ichthammol |
Approved |
Phase 1 |
|
8029-68-3 |
|
Synonyms:
Ammonium bituminosulfonate
Ammonium bituminosulphonate
|
Ammonium sulphoichthyolate
Ichthammol
|
|
45 |
|
Ibuprofen |
Approved |
Phase 1 |
|
15687-27-1 |
3672 |
Synonyms:
(+-)-2-(p-Isobutylphenyl)propionate
(+-)-2-(p-Isobutylphenyl)propionic acid
(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetate
(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid
(+-)-a-Methyl-4-(2-methylpropyl)benzeneacetate
(+-)-a-Methyl-4-(2-methylpropyl)benzeneacetic acid
(+-)-Ibuprofen
(+-)-p-Isobutylhydratropate
(+-)-p-Isobutylhydratropic acid
(+-)-Α-methyl-4-(2-methylpropyl)benzeneacetate
(+-)-Α-methyl-4-(2-methylpropyl)benzeneacetic acid
(±)-2-(P-ISOBUTYLPHENYL)PROPIONIC ACID
(±)-IBUPROFEN
(±)-P-ISOBUTYLHYDRATROPIC ACID
(±)-Α-METHYL-4-(2-METHYLPROPYL)BENZENEACETIC ACID
(4-Isobutylphenyl)-alpha-methylacetate
(4-Isobutylphenyl)-alpha-methylacetic acid
(4-Isobutylphenyl)-a-methylacetate
(4-Isobutylphenyl)-a-methylacetic acid
(4-Isobutylphenyl)-α-methylacetate
(4-Isobutylphenyl)-α-methylacetic acid
(RS)-Ibuprofen
2-(4-Isobutylphenyl)propanoate
2-(4-Isobutylphenyl)propanoic acid
4-Isobutylhydratropate
4-Isobutylhydratropic acid
a-(4-Isobutylphenyl)propionate
a-(4-Isobutylphenyl)propionic acid
a-(p-Isobutylphenyl)propionate
a-(p-Isobutylphenyl)propionic acid
ACHES-N-PAIN
Actiprofen
Adran
Advil
ADVIL LIQUI-GELS
ADVIL MIGRAINE LIQUI-GELS
Advil®|Brufen®|ibuprofen lysine|ibuprofen sodium|Motrin®|Nurofen®|U-18573
alpha-(4-Isobutylphenyl)propionate
alpha-(4-Isobutylphenyl)propionic acid
alpha-(p-Isobutylphenyl)propionate
alpha-(p-Isobutylphenyl)propionic acid
alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid
alpha-p-Isobutylphenylpropionate
alpha-p-Isobutylphenylpropionic acid
Aluminum salt ibuprofen
Amersol
Amibufen
ANADIN JOINT PAIN
ANADIN LIQUIFAST
ANADIN PERIOD PAIN RELIEF
ANADIN ULTRA
Anco
Andran
Anflagen
Apo-Ibuprofen
Apsifen
APSIFEN-F
ARTHROFEN 200
ARTHROFEN 400
ARTHROFEN 600
Artril 300
Bluton
Brufanic
Brufen
BRUFEN RET
Brufort
Buburone
Butylenin
Calcium salt ibuprofen
CALDOLOR
CAP-PROFEN
CHILDREN'S ADVIL
CHILDREN'S ADVIL-FLAVORED
CHILDREN'S ELIXSURE
CHILDREN'S IBUPROFEN
CHILDREN'S MOTRIN
CODAFEN CONTINUS
Codral
CO-OP
CUPROFEN FOR CHILD
CUPROFEN PLUS
DEEP RELIEF
Dolgin
Dolgirid
Dolgit
Dolocyl
Dolo-dolgit
Duralbuprofen
Ebufac
Emodin
Epobron
Femadon
FEMAFEN
FENBID
FENBID FTE
Fenbid Spansule
FENPAED
FEVERFEN
FLEXIMEX
Haltran
I.V. solution, ibuprofen
IB-100
Ibu
Ibu-attritin
IBUCALM
IBUDERM
IBUFAC
Ibufen
IBUGEL
IBUGEL FTE
IBULAR
IBULEVE
IBUMED
Ibumetin
IBUMOUSSE
IBUPRIN
Ibuprocin
IBUPROFEN
Ibuprofen i.v. solution
Ibuprofen zinc
|
Ibuprofen, (+-)-isomer
Ibuprofen, (R)-isomer
Ibuprofen, (S)-isomer
Ibuprofen, aluminum salt
Ibuprofen, calcium salt
Ibuprofen, copper (2+) salt
Ibuprofen, magnesium salt
Ibuprofen, potassium salt
Ibuprofen, sodium salt
Ibuprofen, zinc salt
Ibuprofene
Ibuprofeno
Ibuprofenum
Ibuprofen-zinc
IBUPROHM
IBUPROPHEN
IBU-SLO
IBUSPRAY
IBU-TAB
IBU-TAB 200
Ibutid
IBUTIME
Ifen
Inabrin
Inoven
IP 82
IP-82
ISISFEN
JUNIFEN
JUNIOR STRENGTH ADVIL
JUNIOR STRENGTH IBUPROFEN
JUNIOR STRENGTH MOTRIN
Lamidon
Lebrufen
LIDIFEN
LIDIFEN-F
Liptan
LOBUFEN
M01AE01
Magnesium salt ibuprofen
MANDAFEN
MANORFEN
MAXA-GESIC
Medipren
MIDOL
Midol 200
MIDOL LIQUID GELS
MIGRAFEN
Motrin
MOTRIN IB
MOTRIN MIGRAINE PAIN
Mynosedin
Napacetin
NeoProfen
Nobfelon
Nobfen
Nobgen
NOVAPRIN
Novogent N
Novoprofen
NSC-256857
Nuprin
Nurofen
NUROFEN 400
NUROFEN BACK PAIN SR
NUROFEN CHILD
NUROFEN FOR CHILD
NUROFEN PLUS
NUROFEN RECOVERY
NUROFEN SINUS
NUROFEN SOLB
ORBIFEN
PACIFENE
Pantrop
Para-Isobutylhydratropic Acid
PAXOFEN
PEDEA
Pediaprofen
Pedia-Profen
PEDIATRIC ADVIL
PHENSIC
PHOR PAIN
PHORPAIN
PHORPAIN MAX STRGH
p-Isobutyl-2-phenylpropionate
p-Isobutyl-2-phenylpropionic acid
p-Isobutylhydratropate
p-Isobutylhydratropic acid
Potassium salt ibuprofen
PROFEN
PROFLEX
PROFLEX SR
Rafen
RD 13621
Rebugen
RELCOFEN
RIMAFEN
Roidenin
Rufen
Salprofen
Salt ibuprofen, magnesium
Salt ibuprofen, sodium
Salt ibuprofen, zinc
Seclodin
Sodium salt ibuprofen
Suspren
Tabalon
TAB-PROFEN
Trauma dolgit gel
Trauma-dolgit gel
TraumaDolgit gel
Trendar
U-18573
Urem
Zinc salt ibuprofen
Α-(4-isobutylphenyl)propionate
Α-(4-isobutylphenyl)propionic acid
Α-(p-isobutylphenyl)propionate
Α-(p-isobutylphenyl)propionic acid
|
|
46 |
|
Ranitidine |
Approved, Withdrawn |
Phase 1 |
|
66357-59-3, 82530-72-1, 66357-35-5 |
3001055 5039 |
Synonyms:
(e)-Ranitidine
1-N'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulphanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine
2-(Benzhydryloxy)-N,N-dimethylethylamine
2-Diphenylmethoxy-N,N-demthylethanamine
2-Diphenylmethoxy-N,N-dimethylethylamine
a-(2-Dimethylaminoethoxy)diphenylmethane
Achedos
Acidex
AH-19065|Gavilast®|GR-122311X|Zantac®
Alledryl
Allerdryl
Allergan
Allergina
alpha-(2-Dimethylaminoethoxy)diphenylmethane
Atural
Axoban
b-Dimethylaminoethanol diphenylmethyl ether
b-Dimethylaminoethyl benzhydryl ether
Benadryl
Bendylate
Benhydramin
Benylin
Benzantin
Benzhydramine
beta-Dimethylaminoethanol diphenylmethyl ether
beta-Dimethylaminoethyl benzhydryl ether
Biotidin
Citrate, diphenhydramine
Coralen
Curan
Difenhidramina
Difenhydramine
Dimedrol
Dimedrolum
Dimethyl[(5-{[(2-{[1-(methylamino)-2-nitroethenyl]amino}ethyl)sulphanyl]methyl}furan-2-yl)methyl]amine
Dimethylamine benzhydryl ester
Diphamine
Diphantine
Diphenhydramine citrate
Diphenhydramine citrate (1:1)
Diphenhydramine hydrochloride
Diphenhydraminum
Diphenylhydramin
Diphenylhydramine
Dobacen
Dormin
Duractin
Ezopta
Gastrial
Gastrosedol
Hydrochloride, diphenhydramine
Hydrochloride, ranitidine
Istomar
|
Logast
Mauran
Microtid
N (2-(((5-((dimethylamino)Methyl)-2-furanyl)methyl)thio)ethyl)-n'-methyl-2-nitro-1,1-ethenediamine
N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine
O-Benzhydryldimethylaminoethanol
Ptinolin
Quantor
Quicran
Radinat
RAN
Randin
Ranidine
Ranin
Raniogas
Ranisen
Raniter
Ranitidin
Ranitidina
Ranitidine
Ranitidine (form I and form II)
Ranitidine base
Ranitidine HCL 1/2 type
Ranitidine hydrochloride
Ranitidinum
Ranitiget
Rantacid
Rantidine
Ratic
Raticina
Restamin
RND
Sampep
Sostril
Taural
Tritec
Ulceranin
Ul-pep
Urantac
Verlost
Vesyca
Vizerul
Weichilin
Weidos
Xanidine
Zantab
Zantac
Zantadin
Zantic
Α-(2-dimethylaminoethoxy)diphenylmethane
Β-dimethylaminoethanol diphenylmethyl ether
Β-dimethylaminoethyl benzhydryl ether
|
|
47 |
|
Histamine |
Approved, Investigational |
Phase 1 |
|
51-45-6 |
774 |
Synonyms:
1H-Imidazole-4-ethanamine
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(3H-Imidazol-4-yl)ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-Imidazolyl)ethylamine
2-Imidazol-4-ylethylamine
2-Imidazol-4-yl-ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-Imidazoleethylamine
5-Imidazoleethylamine
|
beta-Aminoethylglyoxaline
beta-Aminoethylimidazole
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
b-Imidazolyl-4-ethylamine
Eramin
Ergamine
Ergotidine
Histamine
HSM
Imidazole-4-ethylamine
NSC-33792
Β-imidazolyl-4-ethylamine
|
|
48 |
|
Diphenhydramine |
Approved, Investigational |
Phase 1 |
|
147-24-0, 58-73-1 |
3100 |
Synonyms:
[2-(DIPHENYLMETHOXY)ETHYL]DIMETHYLAMINE
2-(Benzhydryloxy)-N,N-dimethylethylamine
2-Diphenylmethoxy-N,N-demthylethanamine
2-Diphenylmethoxy-N,N-dimethylethylamine
a-(2-Dimethylaminoethoxy)diphenylmethane
Alledryl
Allerdryl
Allergan
Allergina
alpha-(2-Dimethylaminoethoxy)diphenylmethane
ANTITUSSIVE
b-Dimethylaminoethanol diphenylmethyl ether
b-Dimethylaminoethyl benzhydryl ether
BELDIN
BELIX
Benadryl
BENADRYL PRESERVATIVE FREE
Benadryl®|benzhydramine|dimehydrinate
Bendylate
Benhydramin
Benylin
Benzantin
Benzhydramine
beta-Dimethylaminoethanol diphenylmethyl ether
beta-Dimethylaminoethyl benzhydryl ether
CALADRYL
Citrate, diphenhydramine
COLTEX
DIBENIL
Difenhidramina
Difenhydramine
Dimedrol
Dimedrolum
DIMEHYDRINATE
Dimethylamine benzhydryl ester
Diphamine
Diphantine
|
DIPHEN
DIPHENHYDRAMINE
Diphenhydramine citrate
Diphenhydramine citrate (1:1)
DIPHENHYDRAMINE HCL
Diphenhydramine hydrochloride
DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE
Diphenhydraminum
Diphenylhydramin
Diphenylhydramine
Dobacen
Dormin
DREEMON
DYTUSS
FEDRIL
GPPE COUGH EXPECT PAED
GPPE ORAL SOLN
HISTERGAN
HYDRAMINE
Hydrochloride, diphenhydramine
MEDINEX
N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine
NIGHTCALM
NSC-33299
NYTOL
NYTOL ONE-A-NIGHT
O-Benzhydryldimethylaminoethanol
PAXIDORM
Restamin
SILPHEN
SLEEPIA
SYNTEDRIL
TIXYLIX CATARRH
VICKS FORMULA 44
Α-(2-dimethylaminoethoxy)diphenylmethane
Β-dimethylaminoethanol diphenylmethyl ether
Β-dimethylaminoethyl benzhydryl ether
|
|
49 |
|
Promethazine |
Approved, Investigational |
Phase 1 |
|
60-87-7 |
4927 |
Synonyms:
(2-Dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine
10-(2-Dimethylaminopropyl)phenothiazine
10-[2-(Dimethylamino)propyl]phenothiazine
Atosil
Diphergan
Diprazin
Hydrochloride, promethazine
Isopromethazine
Lilly 1516
N-(2'-Dimethylamino-2'-methyl)ethylphenothiazine
N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine
N,N,a-Trimethyl-10H-phenothiazine-10-ethanamine
N,N,Α-trimethyl-10H-phenothiazine-10-ethanamine
NSC-30321
Phenargan
Phenergan
Phenergan®|Sominex®
Phensedyl
Pipolfen
Pipolphen
Proazaimine
Proazamine
|
Promazinamide
Promet
Prometazin
Prometazina
Prometazine
PROMETHACON
Promethazin
PROMETHAZINE
Promethazine hydrochloride
Promethazinum
PROMETHEGAN
Promethiazine
Promezathine
Prothazin
Prothazine
Pyrethia
Remsed
RP-3277
Rumergan
SOMINEX
ZIPAN-25
ZIPAN-50
|
|
50 |
|
Analgesics |
|
Phase 1 |
|
|
|
Interventional clinical trials:
(show all 44)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Imatinib Mesylate Therapy in Systemic Mastocytosis Patients Lacking KIT Mutations |
Completed |
NCT01297777 |
Phase 4 |
Imatinib Mesylate |
2 |
Subcutaneous Cladribine Plus Pegylated Interpheron Alfa-2a in Advanced Systemic Mastocytosis With D816V and Other Exon 17 KIT Mutations. |
Unknown status |
NCT01602939 |
Phase 2, Phase 3 |
Cladribine and pegylated interpheron alpha-2a |
3 |
Randomized, Placebo-controlled, Phase 3 Study to Compare Efficacy and Safety of Masitinib at 6 mg/kg/Day to Placebo in Treatment of Patients With Smouldering Systemic, Indolent Systemic or Cutaneous Mastocytosis With Handicap |
Completed |
NCT00814073 |
Phase 3 |
Masitinib;Placebo |
4 |
Phase 3 Study to Compare Oral Masitinib to Placebo in Treatment of Patients With Smouldering or Indolent Severe Systemic Mastocytosis, Unresponsive to Optimal Symptomatic Treatment |
Recruiting |
NCT04333108 |
Phase 3 |
Masitinib |
5 |
A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study of BLU-263 in Indolent Systemic Mastocytosis |
Recruiting |
NCT04910685 |
Phase 2, Phase 3 |
BLU-263;Placebo |
6 |
Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis |
Active, not recruiting |
NCT03401060 |
Phase 3 |
Denosumab;Placebo |
7 |
Hydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement Patients: Proof of Concept Study |
Not yet recruiting |
NCT05084872 |
Phase 2, Phase 3 |
Hydroxychloroquine |
8 |
Phase II Single Arm Open Pilot Study to Demonstrate the Efficacy of Midostaurin in Symptom Improvement and Decrease of Mast Cell Burden in Patients With Indolent or Smoldering Systemic Mastocytosis. |
Unknown status |
NCT01920204 |
Phase 2 |
Midostaurin, |
9 |
Multicenter, Open-Label, Single Arm Phase II Clinical Trial of Dasatinib in the Treatment of Systemic Mastocytosis |
Unknown status |
NCT00979160 |
Phase 2 |
Dasatinib |
10 |
Randomized, Double-blind, Placebo-controlled, Crossover Design, Efficacy and Safety Study With PA101 in Patients With Indolent Systemic Mastocytosis |
Completed |
NCT02478957 |
Phase 2 |
PA101;Placebo |
11 |
A Study of Brentuximab Vedotin (SGN-35) in CD30-Positive Systemic Mastocytosis With or Without an Associated Hematological Clonal Non-Mast Cell Lineage Disease (AHNMD) |
Completed |
NCT01807598 |
Phase 2 |
Brentuximab vedotin |
12 |
Evaluation of RAD001 as Therapy for Patients With Systemic Mastocytosis |
Completed |
NCT00449748 |
Phase 2 |
RAD001 (Everolimus) |
13 |
ONTAK (Denileukin Diftitox) in Patients With Systemic Mastocytosis |
Completed |
NCT00493129 |
Phase 2 |
Ontak (Denileukin Diftitox) |
14 |
Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes |
Completed |
NCT00171912 |
Phase 2 |
imatinib mesylate |
15 |
A Phase IA/II Multicenter, Dose-escalation Study of Oral AMN107 on a Continuous Daily Dosing Schedule in Adult Patients With Imatinib-resistant/Intolerant CML in Chronic or Accelerated Phase or Blast Crisis, Relapsed/Refractory Ph+ ALL, and Other Hematologic Malignancies. |
Completed |
NCT00109707 |
Phase 1, Phase 2 |
Nilotinib |
16 |
A Single Arm, Phase 2, Open-Label Study to Determine the Efficacy of Twice Daily Oral Dosing of PKC412 <Midostaurin> Administered to Patients With Aggressive Systemic Mastocytosis (ASM) and Mast Cell Leukemia (MCL) |
Completed |
NCT00233454 |
Phase 2 |
Midostaurin |
17 |
A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease |
Completed |
NCT00782067 |
Phase 2 |
Midostaurin (PKC412) |
18 |
A Phase II Clinical Trial of 17-(Allylamino)-17- Demethoxygeldanamycin (17-AAG, NSC 330507 and EPL Diluent, NSC 704057) in Adults With Systemic Mastocytosis |
Completed |
NCT00132015 |
Phase 2 |
tanespimycin |
19 |
Low Intensity Preparative Regimen Followed by HLA-Matched, Mobilized Peripheral Blood Stem Cell Transplantation for Systemic Mastocytosis |
Completed |
NCT00006413 |
Phase 2 |
|
20 |
Phase II Study of Thalidomide in Mastocytosis |
Completed |
NCT00769587 |
Phase 2 |
thalidomide |
21 |
A Phase 2 Open-Label, Multicenter Clinical Study of the Safety, Efficacy, Pharmacokinetic, and Pharmacodynamic Profiles of CGT9486 as a Single Agent in Patients With Advanced Systemic Mastocytosis |
Recruiting |
NCT04996875 |
Phase 2 |
CGT9486 tablets |
22 |
A Phase 2 Randomized Double-Blinded Placebo-Controlled Study to Evaluate the Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in Subjects With Indolent Systemic Mastocytosis |
Recruiting |
NCT03770273 |
Phase 2 |
|
23 |
Tagraxofusp (SL-401) in Patients With Chronic Myelomonocytic Leukemia (CMML) or Myelofibrosis (MF). [Prior Title: SL-401 in Patients With Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Primary Eosinophilic Disorder, Myelofibrosis, Chronic Myelomonocytic Leukemia).] |
Recruiting |
NCT02268253 |
Phase 2 |
SL-401 |
24 |
A Multi-Part, Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study of The Safety and Efficacy of CGT9486 in Subjects With Nonadvanced Systemic Mastocytosis |
Recruiting |
NCT05186753 |
Phase 2 |
CGT9486 Tablets;Placebo Tablets |
25 |
An Open-label, Single Arm, Phase 2 Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis |
Active, not recruiting |
NCT03580655 |
Phase 2 |
Avapritinib |
26 |
A 3-Part, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate Safety and Efficacy of Avapritinib (BLU-285), a Selective KIT Mutation-Targeted Tyrosine Kinase Inhibitor, in Indolent and Smoldering Systemic Mastocytosis With Symptoms Inadequately Controlled With Standard Therapy |
Active, not recruiting |
NCT03731260 |
Phase 2 |
Avapritinib;Placebo |
27 |
A Phase 1/2, Open-label, 2-arm Study Evaluating BLU-263 as Monotherapy and in Combination With Azacitidine, in Patients With KIT Altered Hematologic Malignancies |
Not yet recruiting |
NCT05609942 |
Phase 1, Phase 2 |
BLU-263;Azacitidine |
28 |
A Phase 2 Study of Ibrutinib in Advanced Systemic Mastocytosis |
Terminated |
NCT02415608 |
Phase 2 |
Ibrutinib |
29 |
Evaluation of Obatoclax Mesylate as Therapy for Patients With Systemic Mastocytosis |
Terminated |
NCT00918931 |
Phase 2 |
Obatoclax Mesylate |
30 |
GTB-3550 (CD16/IL-15/CD33)Tri-Specific Killer Engager (TriKE®) for the Treatment of High Risk Myelodysplastic Syndromes, Refractory/Relapsed Acute Myeloid Leukemia and Advanced Systemic Mastocytosis |
Terminated |
NCT03214666 |
Phase 1, Phase 2 |
GTB-3550 TriKE® Phase I;GTB-3550 TriKE® Phase II |
31 |
A Phase 2 Study to Evaluate the Anti-Tumor Activity of Single Agent Flotetuzumab in Advanced CD123-Positive Hematological Malignancies |
Withdrawn |
NCT03739606 |
Phase 2 |
|
32 |
A Multicenter Phase 1, Open-Label Study of DCC-2618 to Assess Safety, Tolerability, Efficacy, and Pharmacokinetics in Patients With Advanced Malignancies |
Completed |
NCT02571036 |
Phase 1 |
DCC-2618 |
33 |
A Phase 1, Single Ascending Dose and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002 in Patients With Indolent Systemic Mastocytosis |
Completed |
NCT02808793 |
Phase 1 |
AK002 |
34 |
A Phase 1 Trial to Evaluate the Safety of Single Agent Flotetuzumab in Advanced CD123-Positive Hematological Malignancies |
Recruiting |
NCT04681105 |
Phase 1 |
Acetaminophen;Dexamethasone;Diphenhydramine;Ibuprofen;Ranitidine |
35 |
A Phase 1, First-in-Human, Dose Escalation Study of MGD024, a CD123 x CD3 Bispecific DART Molecule, in Patients With Select Relapsed or Refractory Hematologic Malignancies |
Recruiting |
NCT05362773 |
Phase 1 |
MGD024 |
36 |
A Phase 1 Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies |
Active, not recruiting |
NCT02561988 |
Phase 1 |
Avapritinib |
37 |
An External Control, Observational, Retrospective Study Assessing the Effect of Avapritinib Compared With Best Available Therapy for Patients With Advanced Systemic Mastocytosis |
Completed |
NCT04695431 |
|
|
38 |
Patient-Reported Outcome Questionnaire Development for Symptoms of Systemic Mastocytosis |
Completed |
NCT02380222 |
|
|
39 |
Adaptation of the Questionnaire "Regarding Patient's Quality of Life With Mastocytosis" in the French Language |
Completed |
NCT03632811 |
|
|
40 |
Evaluation of the Diagnostic Value of Level of Bone Marrow Tryptase in Adult Systemic Mastocytosis |
Completed |
NCT02441166 |
|
|
41 |
Treatment of Systemic Mastocytosis With Tamoxifen |
Completed |
NCT01334996 |
|
|
42 |
Determination of Cytokine Production Patterns in the Skin of Patients With Systemic Mastocytosis and Atopic Dermatitis Using the Suction Blister Technique |
Completed |
NCT00001760 |
|
|
43 |
Expanded Access Program (EAP) for Avapritinib |
Available |
NCT04714086 |
|
Avapritinib |
44 |
A Retrospective and Prospective Multicenter Observational Study for the Evaluation of Incidence of Systemic Mastocytosis With Associated t(8;21) Acute Myeloid Leukemia in t(8;21) Acute Myeloid Leukemia |
Not yet recruiting |
NCT05504408 |
|
|
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
imatinib
|
Imatinib mesylate
|
Cell-based therapeutics:
Data from LifeMap, the Embryonic Development and Stem Cells Database
Stem-cell-based therapeutic approaches for Systemic Mastocytosis:
Embryonic/Adult Cultured Cells Related to Systemic Mastocytosis:
|